Does intracerebroventricular administration of bacterial lipopolysaccharide prevent the development of acute experimental pancreatitis in the rat?
Pretreatment with LPS given i.c.v. prevents the development of caerulein-induced pancreatitis through the activation of SN and though the release of leptin.
EDN levels have predictive value for the development of recurrent wheezing post-RSV bronchiolitis.